Webinar
02
Dec
2025
2025
18
00
CET
CET
Tumour sites
Definition of high-risk patients and treatment escalation in EBC: role of pathologists and diagnostics in high-risk definitions and its impact on treatment decisions
Facebook
Linkedin
X
Send a mailThis webinar will explore how pathologists and diagnostic assessments contribute to defining high-risk patients in early breast cancer (EBC) and guiding treatment escalation. Speakers will cover common pitfalls in pathology reporting, risk assessment in ER-positive disease, and how accurate high-risk classification can influence treatment decisions, including the use of CDK4/6 inhibitors.
Speakers
Discussant
Giuseppe Curigliano
University of Milan and European Institute of Oncology, Milan, Italy
Expert
Angela DeMichele
University of Pennsylvania, Philadelphia, USA
Expert
Zsuzsanna Varga
University Hospital Zurich, Zurich, Switzerland